CDC panel adjourns without vote on extending Johnson & Johnson COVID vaccine pause
CBSN
A Centers for Disease Control and Prevention advisory committee did not vote Wednesday on whether to extend the nation's pause on Johnson & Johnson's COVID-19 vaccine, after experts on the panel argued there was still insufficient data to make final recommendations in light of the serious, rare blood clotting events potentially linked to the shots.
While the CDC's current pause on Johnson & Johnson's vaccine is not binding, the warning issued by federal health officials on Tuesday urged that vaccinations be suspended only until the panel voted on "updated recommendations" for using the vaccine. In response to the FDA and CDC advisory on the pause, all states and D.C. and Puerto Rico have opted to temporarily stop administering this vaccine. The CDC has yet to decide on a date to resume the panel's discussion on the topic.
A jury on Wednesday found that Meta and YouTube are liable for creating products that led to harmful and addictive behavior by young users, a landmark decision that could set a legal precedent for similar allegations brought against social media companies. Edited by Alain Sherter and Aimee Picchi In:

An internal watchdog report in the Department of Homeland Security identified serious vulnerabilities in TSA's screenings at airports nationwide — and the agency has yet to respond five months later, according to internal communications provided to House Homeland Security Committee staff and reviewed by CBS News.











